Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $12.48 billion. The enterprise value is $12.26 billion.
| Market Cap | 12.48B |
| Enterprise Value | 12.26B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 141.25 million shares outstanding. The number of shares has increased by 7.74% in one year.
| Current Share Class | 141.25M |
| Shares Outstanding | 141.25M |
| Shares Change (YoY) | +7.74% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 3.32% |
| Owned by Institutions (%) | 75.34% |
| Float | 121.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.64 |
| Forward PS | 90.23 |
| PB Ratio | 26.78 |
| P/TBV Ratio | 27.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.90, with a Debt / Equity ratio of 2.96.
| Current Ratio | 5.90 |
| Quick Ratio | 5.71 |
| Debt / Equity | 2.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.45 |
Financial Efficiency
Return on equity (ROE) is -55.21% and return on invested capital (ROIC) is -101.07%.
| Return on Equity (ROE) | -55.21% |
| Return on Assets (ROA) | -8.10% |
| Return on Invested Capital (ROIC) | -101.07% |
| Return on Capital Employed (ROCE) | -12.38% |
| Weighted Average Cost of Capital (WACC) | 10.76% |
| Revenue Per Employee | $941,624 |
| Profits Per Employee | -$450,007 |
| Employee Count | 711 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $20.05 million in taxes.
| Income Tax | 20.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +437.94% in the last 52 weeks. The beta is 1.29, so ARWR's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +437.94% |
| 50-Day Moving Average | 79.97 |
| 200-Day Moving Average | 66.68 |
| Relative Strength Index (RSI) | 59.36 |
| Average Volume (20 Days) | 2,093,682 |
Short Selling Information
The latest short interest is 9.64 million, so 6.82% of the outstanding shares have been sold short.
| Short Interest | 9.64M |
| Short Previous Month | 8.43M |
| Short % of Shares Out | 6.82% |
| Short % of Float | 7.93% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, ARWR had revenue of $669.50 million and -$319.96 million in losses. Loss per share was -$2.28.
| Revenue | 669.50M |
| Gross Profit | 669.50M |
| Operating Income | -226.44M |
| Pretax Income | -252.08M |
| Net Income | -319.96M |
| EBITDA | -194.25M |
| EBIT | -226.44M |
| Loss Per Share | -$2.28 |
Balance Sheet
The company has $1.60 billion in cash and $1.38 billion in debt, with a net cash position of $218.46 million or $1.55 per share.
| Cash & Cash Equivalents | 1.60B |
| Total Debt | 1.38B |
| Net Cash | 218.46M |
| Net Cash Per Share | $1.55 |
| Equity (Book Value) | 466.04M |
| Book Value Per Share | 3.30 |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was -$59.06 million and capital expenditures -$16.06 million, giving a free cash flow of -$75.11 million.
| Operating Cash Flow | -59.06M |
| Capital Expenditures | -16.06M |
| Depreciation & Amortization | 25.80M |
| Net Borrowing | 585.27M |
| Free Cash Flow | -75.11M |
| FCF Per Share | -$0.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -33.82% and -47.79%.
| Gross Margin | 100.00% |
| Operating Margin | -33.82% |
| Pretax Margin | -37.65% |
| Profit Margin | -47.79% |
| EBITDA Margin | -29.01% |
| EBIT Margin | -33.82% |
| FCF Margin | n/a |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.74% |
| Shareholder Yield | -7.74% |
| Earnings Yield | -2.56% |
| FCF Yield | -0.60% |
Analyst Forecast
The average price target for ARWR is $110.18, which is 24.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $110.18 |
| Price Target Difference | 24.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -7.47% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 2.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.1 |
| Piotroski F-Score | 2 |